These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Screening for trisomy 21 by fetal tricuspid regurgitation, nuchal translucency and maternal serum free beta-hCG and PAPP-A at 11 + 0 to 13 + 6 weeks. Falcon O; Auer M; Gerovassili A; Spencer K; Nicolaides KH Ultrasound Obstet Gynecol; 2006 Feb; 27(2):151-5. PubMed ID: 16388509 [TBL] [Abstract][Full Text] [Related]
4. Screening for trisomy at 11-13 weeks' gestation: use of pregnancy-associated plasma protein-A, placental growth factor or both. Mazer Zumaeta A; Wright A; Syngelaki A; Maritsa VA; Bardani E; Nicolaides KH Ultrasound Obstet Gynecol; 2020 Sep; 56(3):408-415. PubMed ID: 32621353 [TBL] [Abstract][Full Text] [Related]
5. Serum parameters and nuchal translucency in first trimester screening for fetal chromosomal abnormalities. Zimmermann R; Hucha A; Savoldelli G; Binkert F; Achermann J; Grudzinskas JG Br J Obstet Gynaecol; 1996 Oct; 103(10):1009-14. PubMed ID: 8863700 [TBL] [Abstract][Full Text] [Related]
6. Maternal serum biochemistry at 11-13(+6) weeks in relation to the presence or absence of the fetal nasal bone on ultrasonography in chromosomally abnormal fetuses: an updated analysis of integrated ultrasound and biochemical screening. Cicero S; Spencer K; Avgidou K; Faiola S; Nicolaides KH Prenat Diagn; 2005 Nov; 25(11):977-83. PubMed ID: 16245371 [TBL] [Abstract][Full Text] [Related]
7. A screening program for trisomy 21 at 10-14 weeks using fetal nuchal translucency, maternal serum free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A. Spencer K; Souter V; Tul N; Snijders R; Nicolaides KH Ultrasound Obstet Gynecol; 1999 Apr; 13(4):231-7. PubMed ID: 10341399 [TBL] [Abstract][Full Text] [Related]
8. The clinical usefulness of biochemical (free β-hCg, PaPP-a) and ultrasound (nuchal translucency) parameters in prenatal screening of trisomy 21 in the first trimester of pregnancy. Ziolkowska K; Dydowicz P; Sobkowski M; Tobola-Wrobel K; Wysocka E; Pietryga M Ginekol Pol; 2019; 90(3):161-166. PubMed ID: 30950006 [TBL] [Abstract][Full Text] [Related]
9. Screening for aneuploidies by maternal age, fetal nuchal translucency and maternal serum biochemistry at 11-13+6 gestational weeks. Karadzov-Orlić N; Egić A; Filimonović D; Marinković M; Damnjanović-Pazin B; Milovanović Z; Joksić I; Branković S; Lukić R; Mandić V; Cerović N; Mojović D; Plamenac S; Stanković M; Maglić D; Mikovć Z Srp Arh Celok Lek; 2012; 140(9-10):606-11. PubMed ID: 23289277 [TBL] [Abstract][Full Text] [Related]
10. First-trimester combined screening for trisomy 21 with different combinations of placental growth factor, free β-human chorionic gonadotropin and pregnancy-associated plasma protein-A. Kagan KO; Hoopmann M; Abele H; Alkier R; Lüthgens K Ultrasound Obstet Gynecol; 2012 Nov; 40(5):530-5. PubMed ID: 22611005 [TBL] [Abstract][Full Text] [Related]
11. The significance of maternal blood pregnancy-associated plasma protein A (PAPP-A) and free beta-subunit of human chorionic gonadotropin (β-hCG) levels for the risk assessment of fetal trisomy 18 during the first prenatal testing between 11 and 13+6 weeks of pregnancy. Ziolkowska K; Tobola-Wrobel K; Dydowicz P; Zurawski S; Pietryga M; Wysocka E Ginekol Pol; 2020; 91(12):748-754. PubMed ID: 33447994 [TBL] [Abstract][Full Text] [Related]
12. [Study on several ultrasound markers combined maternal serum biochemical markers to screen fetal chromosomal aneuploidy at 11 to 13(+)6 weeks of gestation]. Chen X; Chang Y; Cui HY; Ren CC; Yu BY Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):815-8. PubMed ID: 24444556 [TBL] [Abstract][Full Text] [Related]
13. First-trimester screening for trisomy 21 by free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A: impact of maternal and pregnancy characteristics. Kagan KO; Wright D; Spencer K; Molina FS; Nicolaides KH Ultrasound Obstet Gynecol; 2008 May; 31(5):493-502. PubMed ID: 18432600 [TBL] [Abstract][Full Text] [Related]
14. [Evaluation of pregnancy-associated plasma protein A (PAPP-A) and free beta subunit of human chorionic gonadotropin (beta hCG) levels and sonographic assesement of fetal nuchal translucency (NT) in singleton pregnancies between 11 and 14 weeks of gestation--Polish multi-centre research]. Borowski D; Czuba B; Cnota W; Hincz P; Czekierdowski A; Gajewska J; Jaczyńska R; Ceran A; Włoch A; Wyrwas D; Wiełgoś M; Szymusik I; Szaflik K; Sodowski K Ginekol Pol; 2007 May; 78(5):384-7. PubMed ID: 17867331 [TBL] [Abstract][Full Text] [Related]